Journal Article Summary
The article investigates the genetic factors associated with the "atopic march," a progression where eczema often leads to asthma in children. This topic is significant because understanding the genetic underpinnings of this sequence can help identify individuals at risk for developing asthma after experiencing eczema, which affects a substantial number of children. By exploring these genetic links, researchers aim to uncover potential therapeutic targets that could prevent or mitigate the development of asthma in children with eczema.
In this study, the authors conducted a genome-wide association study (GWAS) involving 12 different populations, including 2,428 cases of children with eczema and asthma and 17,034 controls. They identified seven genetic loci that are significantly associated with the atopic march, including two novel loci that had not been previously linked to allergic diseases. The findings suggest that genetic factors related to eczema play a crucial role in the progression to asthma, highlighting the importance of early intervention in children with eczema to potentially prevent asthma development.
However, the study has limitations, including potential biases in the selection of control groups and the reliance on retrospective data, which may affect the accuracy of the findings. Patients and caregivers should discuss these results with healthcare professionals, especially if there is a family history of eczema or asthma. Understanding the genetic risks can help in monitoring and managing these conditions more effectively, and healthcare providers may offer personalized strategies to reduce the risk of asthma in children with eczema.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Marenholz Ingo, Esparza-Gordillo Jorge, Rüschendorf Franz, Bauerfeind Anja, Strachan David P., Spycher Ben D., Baurecht Hansjörg, Margaritte-Jeannin Patricia, et al.. Meta-analysis identifies seven susceptibility loci involved in the atopic march. Nature Communications 2015. DOI: 10.1038/ncomms9804. PMID: 26542096. PMCID: PMC4667629.
Featured Pill Pals Product
Loratadine 10 mg --- 300 Count Bottle --- Generic For Claritin --- Major / Rugby --- Over The Counter
Loratadine 10 mg — 300 Count Bottle — Generic For Claritin — Major / Rugby — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
